Recent advances in the pathobiology of Hodgkin's lymphoma: Potential impact on diagnostic, predictive, and therapeutic strategies

Advances in Hematology

Volumn 2011, Issue , 2011, Pages

  Banerjee, Diponkar ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; BENDAMUSTINE; BRENTUXIMAB VEDOTIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; GEMCITABINE; IFOSFAMIDE; IRATUMUMAB; LENALIDOMIDE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; NOTCH1 RECEPTOR; OXALIPLATIN; PREDNISONE; PROTEIN BCL 6; RITUXIMAB; SGN 30; UNCLASSIFIED DRUG; VINCRISTINE;

AGE DISTRIBUTION; ASPIRATION BIOPSY; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CLASSICAL HODGKIN LYMPHOMA; CLINICAL FEATURE; DRUG DOSE INCREASE; EPSTEIN BARR VIRUS; FLOW CYTOMETRY; GENE DOSAGE; GENE EXPRESSION PROFILING; GREY ZONE LYMPHOMA; HISTOLOGY; HODGKIN DISEASE; HUMAN; IMMUNOHISTOCHEMISTRY; LARGE CELL LYMPHOMA; LYMPHOMA; MICROSATELLITE MARKER; OVERALL SURVIVAL; PATHOLOGY; PERIPHERAL T CELL LYMPHOMA; PREDICTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REED STERNBERG CELL; REVIEW; SENSITIVITY AND SPECIFICITY; TUMOR MICROENVIRONMENT;

EID: 79952212464     PISSN: 16879104     EISSN: 16879112     Source Type: Journal    
DOI: 10.1155/2011/439456     Document Type: Review

References (258)

1. Hodgkin T., On some morbid appearances of the absorbent glands and spleen Medico-Chirurgical Transactions 1832 17 68 114
2. Hodgkin T., Lister J. J., Notice of some microscopic observations of the blood and animal tissue Philosophical Magazine 1827 2 130 138
3. Poston R. N., A new look at the original cases of H (Pubitemid 29366630)
4. Dawson P. J., The original illustrations of Hodgkin's disease Annals of Diagnostic Pathology 1999 3 6 386 393
5. Jackson H. Jr., Parker F., Hodgkins disease. II. Pathology New England Journal of Medicine 1944 231 35 44
6. Lukes R. J., Butler J. J., The pathology and nomenclature of Hodgkin's disease Cancer Research 1966 26 6 1063 1083
7. Lukes R. J., Craver L., Hal l. T., Rappaport H., Ruben P., Report of the nomenclature committee Cancer Research 1966 26, article 1311
8. Harris N. L., Jaffe E. S., Stein H., Banks P. M., Chan J. K. C., Cleary M. L., Delsol G., De Wolf-Peeters C., Falini B., Gatter K. C., Grogan T. M., Isaacson P. G., Knowles D. M., Mason D. Y., Muller-Hermelink H. K., Pileri S. A., Piris M. A., Ralfkiaer E., Warnke R. A., A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group Blood 1994 84 5 1361 1392 (Pubitemid 24273002)
9. Swerdlow S. H., Campo E., Harris N. L., WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues 2008 4th Lyon, France IARC Press
10. Canadian Cancer Society's Steering Committee, Canadian Cancer Statistics 2010. Canadian Cancer Society, 2010
11. Diepstra A., Niens M., te Meerman G. J., Poppema S., van den Berg A., Genetic susceptibility to Hodgkin's lymphoma associated with the human leukocyte antigen region European Journal of Haematology, Supplement 2005 75 66 34 41 (Pubitemid 40879619)
12. GLOBOCAN 2008, International Agency for Research on Cancer, 2008, http://globocan.iarc.fr/
13. Epstein M. A., Achong B. G., Various forms of Epstein Barr virus infection in man: established facts and a general concept Lancet 1973 2 7833 836 839
14. Punnett A., Tsang R. W., Hodgson D. C., Hodgkin lymphoma across the age spectrum: epidemiology, therapy, and late effects Seminars in Radiation Oncology 2010 20 1 30 44
15. Eberle F. C., Mani H., Jaffe E. S., Histopathology of Hodgkin's lymphoma Cancer Journal 2009 15 2 129 137
16. Horner M. J. R. L., Krapcho M., Neyman N., SEER Cancer Statistics Review, 19752006, National Cancer Institute. November 2008, SEER data submission, posted to the SEER web site, Bethesda, Md, USA, 2009 http://seer.cancer.gov/csr/ 19752006/
17. Connors J. M., Clinical manifestations and natural history of Hodgkin's lymphoma Cancer Journal 2009 15 2 124 128
18. Dinand V., Arya L. S., Epidemiology of childhood Hodgkin's disease: is it different in developing countries? Indian Pediatrics 2006 43 2 141 147
19. Siddiqui N., Ayub B., Badar F., Zaidi A., Hodgkin's lymphoma in Pakistan: a clinico-epidemiological study of 658 cases at a cancer center in Lahore Asian Pacific Journal of Cancer Prevention 2006 7 4 651 655
20. Karimi M., Yarmohammadi H., Ghavanini A. A., Kumar P. V., Epidemiological surveillance of pediatric Hodgkin's disease in southern Iran Medical Science Monitor 2002 8 8 CR572 CR575
21. Sissolak G., Sissolak D., Jacobs P., Human immunodeficiency and Hodgkin lymphoma Transfusion and Apheresis Science 2010 42 2 131 139
22. Mounier N., Spina M., Spano J. P., Hodgkin lymphoma in HIV positive patients Current HIV Research 2010 8 2 141 146
23. Carbone A., Gloghini A., Serraino D., Spina M., HIV-associated Hodgkin lymphoma Current Opinion in HIV and AIDS 2009 4 1 3 10
24. Gloghini A., Carbone A., Why would the incidence of HIV-associated Hodgkin lymphoma increase in the setting of improved immunity? International Journal of Cancer 2007 120 12 2753 2754 (Pubitemid 46651304)
25. Palmieri C., Treibel T., Large O., Bower M., AIDS-related non-Hodgkin's lymphoma in the first decade of highly active antiretroviral therapy Quarterly Journal of Medicine 2006 99 12 811 826 (Pubitemid 46024093)
26. Proctor S. J., Wilkinson J., Sieniawski M., Hodgkin lymphoma in the elderly: a clinical review of treatment and outcome, past, present and future Critical Reviews in Oncology/Hematology 2009 71 3 222 232
27. Meyer N., Paul C., Misery L., Pruritus in cutaneous T-cell lymphomas: frequent, often severe and difficult to treat Acta Dermato-Venereologica 2010 90 1 12 17
28. Weisshaar E., Dalgard F., Epidemiology of itch: adding to the burden of skin morbidity Acta Dermato-Venereologica 2009 89 4 339 350
29. Hiramanek N., Itch: a symptom of occult disease Australian Family Physician 2004 33 7 495 499
30. Omidvari S., Khojasteh H. N., Mohammadianpanah M., Monabati A., Mosalaei A., Ahmadloo N., Long-term pruritus as the initial and sole clinical manifestation of occult Hodgkin's disease Indian Journal of Medical Sciences 2004 58 6 250 252 (Pubitemid 38952574)
31. Stadie V., Marsch W. C. H., Itching attacks with generalized hyperhydrosis as initial symptoms of Hodgkin's disease Journal of the European Academy of Dermatology and Venereology 2003 17 5 559 561 (Pubitemid 37138897)
32. Cavalli F., Rare syndromes in Hodgkin's disease Annals of Oncology 1998 9 5 S109 S113
33. Gonalves F., Thalidomide for the control of severe paraneoplastic pruritus associated with Hodgkin's disease American Journal of Hospice and Palliative Medicine 2010 27 7 486 487
34. Radossi P., Tison T., Vianello F., Dazzi F., Intractable pruritus in non-Hodgkin lymphoma/CLL: rapid response to IFN British Journal of Haematology 1996 94 3 579 (Pubitemid 26284086)
35. Bichel J. O., Bastrup-Madsen P., Alcohol pain in Hodgkin's disease Lancet 1953 261 6764 764 766
36. de Winter J., Alcohol-induced pain in Hodgkin's disease British Medical Journal 1953 2 604 605
37. Hall C., Olson K., Alcohol-induced pain in Hodgkin's disease New England Journal of Medicine 1955 253 608 609
38. Conn H., Alcohol-induced pain as a manifestation of Hodgkin's disease; an investigation of its specificity and frequency Archives of Internal Medicine 1957 100 241 247
39. Braun W. E., Shnider B. I., Alcohol-induced pain in Hodgkin's disease Journal of the American Medical Association 1958 168 14 1882 1885
40. James A. H., Hodgkin's disease with and without alcohol-induced pain. A clinical and histological comparison Quarterly Journal of Medicine 1960 29 47 66
41. Wanka J., Alcohol-induced pain associated with adenocarcinoma of the bronchus British Medical Journal 1965 2 88 89
42. Brewin T. B., Alcohol intolerance in neoplastic disease British Medical Journal 1966 5511 437 441
43. Bichel J., Is the alcohol-intolerance syndrome in Hodgkin's disease disappearing? Lancet 1972 1 7759, article 1069
44. Atkinson K., Austin D. E., McElwain T. J., Peckham M. J., Alcohol pain in Hodgkin's disease Cancer 1976 37 2 895 899
45. Ershler W. B., Petry R. W., Hafez G. R., Goswitz J. T., Alcohol-induced genital pain in recurrent Hodgkin's disease Journal of the American Medical Association 1979 242 10, article 1064
46. Bobrove A. M., Alcohol-related pain and Hodgkin's disease Western Journal of Medicine 1983 138 6 874 875 (Pubitemid 13059072)
47. Callahan B. C., Coe R., Place H. M., Hodgkin disease of the spine presenting as alcohol-related pain. A case report and review of the literature Journal of Bone and Joint Surgery A 1994 76 1 119 121 (Pubitemid 24081813)
48. Custodi P., Cerutti A., Bagnato R., Cassani P., Alcohol-induced pain in tuberculous adenitis Haematologica 1993 78 6 416 417 (Pubitemid 24071679)
49. Snchez-Aguilera A., Montalbn C., de la Cueva P., Snchez-Verde L., Morente M. M., Garca-Coso M., Garca-Laraa J., Bellas C., Provencio M., Romagosa V., Fernndez De Sevilla A., Menrguez J., Sabn P., Mestre M. J., Mndez M., Fresno M. F., Nicols C., Piris M. A., Garca J. F., Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphoma Blood 2006 108 2 662 668 (Pubitemid 44061368)
50. Miranda H. F., Prieto J. C., Puig M. M., Pinardi G., Isobolographic analysis of multimodal analgesia in an animal model of visceral acute pain Pharmacology Biochemistry and Behavior 2008 88 4 481 486 (Pubitemid 350266792)
51. Richards E. M., Marcus R. E., Difficulty in the staging of Hodgkin's disease due to the coexistence of reactive lymphadenopathy Leukemia and Lymphoma 1993 9 4-5 413 417 (Pubitemid 23209524)
52. Magrath I. T., Fine needle aspiration in the diagnosis of childhood malignant disease in Uganda British Journal of Cancer 1973 28 6 477 487
53. Kardos T. F., Vinson J. H., Behm F. G., Frable W. J., O'Dowd G. J., Hodgkin's disease: diagnosis by fine-needle aspiration biopsy: analysis of cytologic criteria from a selected series American Journal of Clinical Pathology 1986 86 3 286 291 (Pubitemid 16023552)
54. Flint A., Kumar N. B., Naylor B., Pulmonary Hodgkin's disease. Diagnosis by fine needle aspiration Acta Cytologica 1988 32 2 221 225 (Pubitemid 18091153)
55. Fulciniti F., Zeppa P., Vetrani A., Troncone G., Palombini L., Hodgkin's disease mimicking suppurative lymphadenitis: a possible pitfall in fine-needle aspiration biopsy cytology Diagnostic cytopathology 1989 5 3 282 285
56. Corrigan C., Sewell C., Martin A., Recurrent Hodgkin's disease in the breast. Diagnosis of a case by fine needle aspiration and immunocytochemistry Acta Cytologica 1990 34 5 669 672 (Pubitemid 20311885)
57. Das D. K., Gupta S. K., Fine needle aspiration cytodiagnosis of Hodgkin's disease and its subtypes. II. Subtyping by differential cell counts Acta Cytologica 1990 34 3 337 341 (Pubitemid 20182053)
58. Granados R., Pinkus G. S., West P., Cibas E. S., Hodgkin's disease presenting as an enlarged thyroid gland. Report of a case diagnosed by fine needle aspiration Acta Cytologica 1991 35 4 439 442
59. Vailati A., Marena C., Aristia L., Nelva A., Cebrelli C., Ferrari E., Primary Hodgkin's disease of the thyroid: report of a case and a review of the literature Haematologica 1991 76 1 69 71
60. Kragel P. J., Miller L. K., Casafrancisco D., Aspiration cytology of lymphocyte-depleted Hodgkin's lymphoma in a man infected with the human immunodeficiency virus: a case report Acta Cytologica 1992 36 3 395 398
61. Krasne D. L., Naritoku W. Y., Cosgrove M. M., Diagnosis of syncytial (lacunar cell-predominant) nodular sclerosing Hodgkin's disease by fine needle aspiration: a case report Acta Cytologica 1993 37 3 418 422 (Pubitemid 23154082)
62. Fulciniti F., Vetrani A., Zeppa P., Giordano G., Marino M., De Rosa G., Palombini L., Hodgkin's disease: diagnostic accuracy of fine needle aspiration: a report based on 62 consecutive cases Cytopathology 1994 5 4 226 233 (Pubitemid 24265202)
63. Daskalopoulou D., Tamiolakis D., Tsousis S., Apostolikas N., Markidou S., Sources of discrepancies in the diagnosis of Hodgkin's disease by fine needle aspiration Archives d'Anatomie et de Cytologie Pathologiques 1996 44 4 166 173 (Pubitemid 26395618)
64. Grosso L. E., Collins B. T., Dunphy C. H., Ramos R. R., Lymphocyte-depleted Hodgkin's disease: diagnostic challenges by fine- needle aspiration Diagnostic Cytopathology 1998 19 1 66 69 (Pubitemid 28303350)
65. Lewis J. D., Faigel D. O., Dowdy Y., Sack M. J., Salhany K. E., Haynes B., Fox K. R., Ginsberg G. G., Hodgkin's disease diagnosed by endoscopic ultrasound-guided fine needle aspiration of a periduodenal lymph node American Journal of Gastroenterology 1998 93 5 834 836 (Pubitemid 29063935)
66. Chhieng D. C., Cangiarella J. F., Symmans W. F., Cohen J. M., Fine-needle aspiration cytology of Hodgkin disease: a study of 89 cases with emphasis on the false-negative cases Cancer 2001 93 1 52 59
67. Moreland W. S., Geisinger K. R., Utility and outcomes of fine-needle aspiration biopsy in Hodgkin's disease Diagnostic Cytopathology 2002 26 5 278 282 (Pubitemid 34492478)
68. Oertel Y. C., Fine needle aspiration in Hodgkin's disease Acta Cytologica 2002 46 3, article 617
69. Zhang J. R., Raza A. S., Greaves T. S., Cobb C. J., Fine-needle aspiration diagnosis of Hodgkin lymphoma using current WHO classificationre- evaluation of cases from 19992004 with new proposals Diagnostic Cytopathology 2006 34 6 397 402 (Pubitemid 43765033)
70. Zeppa P., Picardi M., Cozzolino I., Troncone G., Lucariello A., De Renzo A., Pane F., Rotoli B., Vetrani A., Palombini L., Fine-needle aspiration cytology in the follow-up of Hodgkin lymphoma Diagnostic Cytopathology 2008 36 7 467 472 (Pubitemid 351897372)
71. Das D. K., Francis I. M., Sharma P. N., Sathar S. A., John B., George S. S., Mallik M. K., Sheikh Z. A., Haji B. E., Pathan S. K., Madda J. P., Mirza K., Ahmed M. S., Junaid T. A., Hodgkin's lymphoma: diagnostic difficulties in fine-needle aspiration cytology Diagnostic Cytopathology 2009 37 8 564 573
72. Walts A. E., Fine-needle aspiration of extranodal Hodgkin's lymphoma misinterpreted as carcinoma Diagnostic Cytopathology 2009 37 4 313 314
73. Koloni S. O., Prasek-Kudrna K., Roso V., Radi-Kristo D., Planinc-Peraica A., Dzebro S., Kardum-Skelin I., Jaksi B., Value of fine-needle aspiration cytology in diagnosis of Hodgkin's lymphoma and anaplastic large cell lymphoma: one centre experience Collegium Antropologicum 2010 34 1 75 79
74. Woodruff R. D., Reviewing histologic diagnosis of lymphoma. Comparison of original and review diagnoses in 269 cases Archives of Pathology and Laboratory Medicine 1981 105 11 573 576 (Pubitemid 11020865)
75. Miller T. P., Byrne G. E., Jones S. J., Mistaken clinical and pathologic diagnoses of Hodgkin's disease: a Southwest Oncology Group Study Cancer Treatment Reports 1982 66 4 645 651 (Pubitemid 12129348)
76. Glaser S. L., Dorfman R. F., Clarke C. A., Expert review of the diagnosis and histologic classification of Hodgkin disease in a population-based cancer registry: Interobserver reliability and impact on incidence and survival rates Cancer 2001 92 2 218 224 (Pubitemid 32664425)
77. Braziel R. M., Oyama K., Mistaken diagnoses of Hodgkin's disease Hematology/Oncology Clinics of North America 1997 11 5 863 892 (Pubitemid 27431150)
78. Bernhards J., Fischer R., Hubner K., Schwarze E.-W., Georgii A., Histopathological classification of Hodgkin's lymphomas Annals of Oncology 1992 3 supplement 4 S31 S33
79. Georgii A., Fischer R., Hubner K., Schwarze E. W., Bernhards J., Classification of Hodgkin's disease biopsies by a panel of four histopathologists: report of 1,140 patients from the German national trial Leukemia and Lymphoma 1993 9 4-5 365 370 (Pubitemid 23209516)
80. Franssila K. O., Heiskala M. K., Heiskala H. J., Epidemiology and histopathology of Hodgkin's disease in Finland Cancer 1977 39 3 1280 1288 (Pubitemid 8081206)
81. Matz L. R., Finlay-Jones L. R., Waters E. D., The Rye classification of a population based series of Hodgkin's disease patients in Western Australia Pathology 1981 13 2 267 276 (Pubitemid 11067069)
82. Dunleavy K., Pittaluga S., Grant N., Gray zone lymphomas: clinical and histological characteristics and treatment with dose-adjusted-EPOCH-R (Abstract # 3590) Proceedings of the 50th ASH Annual Meeting 2008 San Frncisco, Calif, USA
83. Calvo K. R., Traverse-Glehen A., Pittaluga S., Jaffe E. S., Molecular profiling provides evidence of primary mediastinal large B-cell lymphoma as a distinct entity related to classic Hodgkin lymphoma: implications for mediastinal gray zone lymphomas as an intermediate form of B-cell lymphoma Advances in Anatomic Pathology 2004 11 5 227 238
84. Savage K. J., Rare B-cell lymphomas: primary mediastinal, intravascular, and primary effusion lymphoma Cancer Treatment and Research 2008 142 243 264
85. Savage K. J., Primary mediastinal large B-cell lymphoma Oncologist 2006 11 5 488 495 (Pubitemid 43788275)
86. Savage K. J., Al-Rajhi N., Voss N., Paltiel C., Klasa R., Gascoyne R. D., Connors J. M., Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience Annals of Oncology 2006 17 1 123 130 (Pubitemid 43033851)
87. Feuerhake F., Kutok J. L., Monti S., Chen W., LaCasce A. S., Cattoretti G., Kurtin P., Pinkus G. S., De Levai L., Harris N. L., Savage K. J., Neuberg D., Habermann T. M., Dalla-Favera R., Golub T. R., Aster J. C., Shipp M. A., NF B activity, function, and target-gene signatures in primary mediastinal large B-cell lymphoma and diffuse large B-cell lymphoma subtypes Blood 2005 106 4 1392 1399 (Pubitemid 41129606)
88. Savage K. J., Monti S., Kutok J. L., Cattoretti G., Neuberg D., De Leval L., Kurtin P., Dal Cin P., Ladd C., Feuerhake F., Aguiar R. C. T., Li S., Salles G., Berger F., Jing W., Pinkus G. S., Habermann T., Dalla-Favera R., Harris N. L., Aster J. C., Golub T. R., Shipp M. A., The molecular signature of mediastinal large B-cell lymphoma differs from that of other diffuse large B-cell lymphomas and shares features with classical Hodgkin lymphoma Blood 2003 102 12 3871 3879 (Pubitemid 37486965)
89. Rudiger T., Jaffe E. S., Delsol G., deWolf-Peeters C., Gascoyne R. D., Georg A. II, Harris N. L., Kadin M. E., MacLennan K. A., Poppema S., Stein H., Weiss L. E., Mller-Hermelink H. K., Workshop report on Hodgkin's disease and related diseases ('grey zone' lymphoma) Annals of Oncology 1998 9 5 S31 S38
90. Boudov L., Torlakovic E., Delabie J., Reimer P., Pfistner B., Wiedenmann S., Diehl V., Mller-Hermelink H. K., Rdiger T., Nodular lymphocyte-predominant Hodgkin lymphoma with nodules resembling T-cell/histiocyte-rich B-cell lymphoma: differential diagnosis between nodular lymphocyte-predominant Hodgkin lymphoma and T-cell/histiocyte-rich B-cell lymphoma Blood 2003 102 10 3753 3758 (Pubitemid 37409397)
91. Lim M. S., Beaty M., Sorbara L., Cheng R. Z., Pittaluga S., Raffeld M., Jaffe E. S., T-cell/histiocyte-rich large B-cell lymphoma: a heterogeneous entity with derivation from germinal center B cells American Journal of Surgical Pathology 2002 26 11 1458 1466 (Pubitemid 35239422)
92. Zhao F., Nodular lymphocyte-predominant Hodgkin lymphoma or T-cell/histiocyte rich large B-cell lymphoma: the problem in "grey zone" lymphomas International Journal of Clinical and Experimental Pathology 2008 1 300 305
93. Carbone A., Gloghini A., Aiello A., Testi A., Cabras A., B-cell lymphomas with features intermediate between distinct pathologic entities. From pathogenesis to pathology Human Pathology 2010 41 5 621 631
94. Fromm J. R., Thomas A., Wood B. L., Flow cytometry can diagnose classical Hodgkin lymphoma in lymph nodes with high sensitivity and specificity American Journal of Clinical Pathology 2009 131 3 322 332
95. Fromm J. R., Kussick S. J., Wood B. L., Identification and purification of classical Hodgkin cells from lymph nodes by flow cytometry and flow cytometric cell sorting American Journal of Clinical Pathology 2006 126 5 764 780 (Pubitemid 44707628)
96. Hansmann M. L., Kuppers R., Pathology and 'molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas Bailliere's Clinical Haematology 1996 9 3 459 477 (Pubitemid 26362740)
97. Jox A., Wolf J., Diehl V., Hodgkin's disease biology: recent advances Hematological Oncology 1997 15 4 165 171 (Pubitemid 28374885)
98. Stein H., Hummel M., Marafioti T., Anagnostopoulos I., Foss H. D., Molecular biology of Hodgkin's disease Cancer Surveys 1997 30 107 123 (Pubitemid 27371539)
99. Marafioti T., Hummel M., Foss H. D., Laumen H., Korbjuhn P., Anagnostopoulos I., Lammert H., Demel G., Theil J., Wirth T., Stein H., Hodgkin and Reed-Sternberg cells represent an expansion of a single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription Blood 2000 95 4 1443 1450 (Pubitemid 30099859)
100. Kppers R., Schwering I., Bruninger A., Rajewsky K., Hansmann M. L., Biology of Hodgkin's lymphoma Annals of Oncology 2002 13 1 11 18 (Pubitemid 34567395)
101. Thomas R. K., Re D., Wolf J., Diehl V., Part I: Hodgkin's lymphomamolecular biology of Hodgkin and Reed-Sternberg cells Lancet Oncology 2004 5 1 11 18 (Pubitemid 38072555)
102. Bruninger A., Schmitz R., Bechtel D., Renn C., Hansmann M. L., Kppers R., Molecular biology of Hodgkin's and Reed/Sternberg cells in Hodgkin's lymphoma International Journal of Cancer 2006 118 8 1853 1861
103. Mschen M., Rajewsky K., Bruninger A., Baur A. S., Oudejans J. J., Roers A., Hansmann M. L., Kppers R., Rare occurrence of classical Hodgkin's disease as a T cell lymphoma Journal of Experimental Medicine 2000 191 2 387 394 (Pubitemid 30060928)
104. Seitz V., Hummel M., Marafioti T., Anagnostopoulos I., Assaf C., Stein H., Detection of clonal T-cell receptor gamma-chain gene rearrangements Reed-Sternberg cells of classic Hodgkin disease Blood 2000 95 10 3020 3024 (Pubitemid 30321149)
105. Hertel C. B., Zhou X. G., Hamilton-Dutoit S. J., Junker S., Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma Oncogene 2002 21 32 4908 4920
106. Doerr J. R., Malone C. S., Fike F. M., Gordon M. S., Soghomonian S. V., Thomas R. K., Tao Q., Murray P. G., Diehl V., Teitell M. A., Wall R., Patterned CpG methylation of silenced B cell gene promoters in classical Hodgkin lymphoma-derived and primary effusion lymphoma cell lines Journal of Molecular Biology 2005 350 4 631 640
107. Ushmorov A., Leithuser F., Sakk O., Weinhusel A., Popov S. W., Mller P., Wirth T., Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma Blood 2006 107 6 2493 2500 (Pubitemid 43345573)
108. Ushmorov A., Ritz O., Hummel M., Leithuser F., Mller P., Stein H., Wirth T., Epigenetic silencing of the immunoglobulin heavy-chain gene in classical Hodgkin lymphoma-derived cell lines contributes to the loss of immunoglobulin expression Blood 2004 104 10 3326 3334 (Pubitemid 39507153)
109. Jundt F., Anagnostopoulos I., Frster R., Mathas S., Stein H., Drken B., Activated Notch1 signaling promotes tumor cell proliferation and survival in Hodgkin and anaplastic large cell lymphoma Blood 2002 99 9 3398 3403 (Pubitemid 34525322)
110. Mathas S., The pathogenesis of classical Hodgkin's lymphoma: a model for B-cell plasticity Hematology/Oncology Clinics of North America 2007 21 5 787 804 (Pubitemid 47487491)
111. Ehlers A., Oker E., Bentink S., Lenze D., Stein H., Hummel M., Histone acetylation and DNA demethylation of B cells result in a Hodgkin-like phenotype Leukemia 2008 22 4 835 841 (Pubitemid 351552633)
112. Kppers R., Molecular biology of Hodgkin's lymphoma Advances in Cancer Research 2002 84 277 312
113. Braeuninger A., Kppers R., Strickler J. G., Wacker H. H., Rajewsky K., Hansmann M. L., Hodgkin and Reed-Sternberg cells in lymphocyte predominant Hodgkin disease represent clonal populations of germinal center-derived tumor B cells Proceedings of the National Academy of Sciences of the United States of America 1997 94 17 9337 9342 (Pubitemid 27357830)
114. Falini B., Bigerna B., Pasqualucci L., Fizzotti M., Martelli M. F., Pileri S., Pinto A., Carbone A., Venturi S., Pacini R., Cattoretti G., Pescarmona E., Lo Coco F., Pelicci P. G., Anagnastopoulos I., Dalla-Favera R., Flenghi L., Distinctive expression pattern of the BCL-6 protein in nodular lymphocyte predominance Hodgkin's disease Blood 1996 87 2 465 471 (Pubitemid 26030301)
115. Montes-Moreno S., Roncador G., Maestre L., Martnez N., Sanchez-Verde L., Camacho F. I., Cannata J., Martinez-Torrecuadrada J. L., Shen Y., Chan W. C., Piris M. A., Gcet1 (centerin), a highly restricted marker for a subset of germinal center-derived lymphomas Blood 2008 111 1 351 358
116. Dogan A., Bagdi E., Munson P., Isaacson P. G., CD10 and BCL-6 expression in paraffin sections of normal lymphoid tissue and B-cell lymphomas American Journal of Surgical Pathology 2000 24 6 846 852 (Pubitemid 30366272)
117. Masir N., Marafioti T., Jones M., Natkunam Y., Rdiger T., Hansmann M. L., Mason D. Y., Loss of CD19 expression in B-cell neoplasms Histopathology 2006 48 3 239 246
118. Tedoldi S., Mottok A., Ying J., Paterson J. C., Cui Y., Facchetti F., Van Krieken J. H. J. M., Ponzoni M., zkal S., Masir N., Natkunam Y., Pileri S. A., Hansmann M. L., Mason D. Y., Tao Q., Marafioti T., Selective loss of B-cell phenotype in lymphocyte predominant Hodgkin lymphoma Journal of Pathology 2007 213 4 429 440 (Pubitemid 350206515)
119. Renn C., Martn-Subero J. I., Hansmann M.-L., Siebert R., Molecular cytogenetic analyses of immunoglubulin loci in nodular lymphocyte predominant Hodgkin's lymphoma reveal a recurrent IGH-BCL6 juxtaposition Journal of Molecular Diagnostics 2005 7 3 352 356 (Pubitemid 41149650)
120. Wlodarska I., Nooyen P., Maes B., Martin-Subero J. I., Siebert R., Pauwels P., De Wolf-Peeters C., Hagemeijer A., Frequent occurrence of BCL6 rearrangements in nodular lymphocyte predominance Hodgkin lymphoma but not in classical Hodgkin lymphoma Blood 2003 101 2 706 710 (Pubitemid 36077597)
121. Epstein M. A., Achong B. G., Barr Y. M., Virus particles in cultured lymphoblasts from Burkitt's lymphoma Lancet 1964 283 7335 702 703
122. Diehl V., Henle G., Henle W., Kohn G., Demonstration of a herpes group virus in cultures of peripheral leukocytes from patients with infectious mononucleosis Journal of Virology 1968 2 7 663 669
123. Henle G., Henle W., Diehl V., Relation of Burkitt's tumor-associated herpes-ytpe virus to infectious mononucleosis Proceedings of the National Academy of Sciences of the United States of America 1968 59 1 94 101
124. Weiss L. M., Movahed L. A., Warnke R. A., Sklar J., Detection of Epstein-Barr viral genomes in Reed-Sternberg cells of Hodgkin's disease New England Journal of Medicine 1989 320 8 502 506 (Pubitemid 19062526)
125. Uccini S., Monardo F., Stoppacciaro A., Gradilone A., Agliano A. M., Faggioni A., Manzari V., Vago L., Costanzi G., Ruco L. P., Baroni C. D., High frequency of Epstein-Barr virus genome detection in Hodgkin's disease of HIV-positive patients International Journal of Cancer 1990 46 4 581 585 (Pubitemid 20355743)
126. Uhara H., Sato Y., Mukai K., Akao I., Matsuno Y., Furuya S., Hoshikawa T., Shimosato Y., Saida T., Detection of Epstein-Barr virus DNA in Reed-Sternberg cells of Hodgkin's disease using the polymerase chain reaction and in situ hybridization Japanese Journal of Cancer Research 1990 81 3 272 278 (Pubitemid 20117321)
127. Wu T. C., Mann R. B., Charache P., Hayward S. D., Staal S., Lambe B. C., Ambinder R. F., Detection of EBV gene expression in Reed-Sternberg cells of Hodgkin's disease International Journal of Cancer 1990 46 5 801 804
128. Brousset P., Chittal S., Schlaifer D., Icart J., Payen C., Rigal-Huguet F., Voigt J. J., Delsol G., Detection of Epstein-Barr virus messenger RNA in Reed-Sternberg cells of Hodgkin's disease by in situ hybridization with biotinylated probes on specially processed modified acetone methyl benzoate xylene (ModAMeX) sections Blood 1991 77 8 1781 1786
129. Coates P. J., Slavin G., D'Ardenne A. J., Persistence of Epstein-Barr virus in Reed-Sternberg cells throughout the course of Hodgkin's disease Journal of Pathology 1991 164 4 291 297
130. Herbst H., Dallenbach F., Hummel M., Niedobitek G., Pileri S., Muller-Lantzsch N., Stein H., Epstein-Barr virus latent membrane protein expression in Hodgkin and Reed-Sternberg cells Proceedings of the National Academy of Sciences of the United States of America 1991 88 11 4766 4770 (Pubitemid 21914623)
131. Jarrett R. F., Gallagher A., Jones D. B., Alexander F. E., Krajewski A. S., Kelsey A., Adams J., Angus B., Gledhill S., Wright D. H., Cartwright R. A., Onions D. E., Detection of Epstein-Barr virus genomes in Hodgkin's disease: relation to age Journal of Clinical Pathology 1991 44 10 844 848
132. Masih A., Weisenburger D., Duggan M., Armitage J., Bashir R., Mitchell D., Wickert R., Purtilo D. T., Epstein-Barr viral genome in lymph nodes from patients with Hodgkin's disease may not be specific to Reed-Sternberg cells American Journal of Pathology 1991 139 1 37 43
133. Boiocchi M., De Re V., Dolcetti R., Carbone A., Scarpa A., Menestrina F., Association of Epstein-Barr virus genome with mixed cellularity and cellular phase nodular sclerosis Hodgkin's disease subtypes Annals of Oncology 1992 3 4 307 310
134. Khan G., Coates P. J., Kangro H. O., Slavin G., Epstein Barr virus (EBV) encoded small RNAs: targets for detection by in situ hybridisation with oligonucleotide probes Journal of Clinical Pathology 1992 45 7 616 620
135. Knecht H., Joske D. J. L., Bachmann E., Sahli R., Odermatt B. F., Significance of the detection of Epstein-Barr virus DNA in lymph nodes in patients with Hodgkin's disease Leukemia and Lymphoma 1992 8 4-5 319 325 (Pubitemid 23035518)
136. Teramoto N., Akagi T., Yoshino T., Takahashi K., Jeon H. J., Direct detection of Epstein-Barr virus DNA from a single Reed-Sternberg cell of Hodgkin's disease by polymerase chain reaction Japanese Journal of Cancer Research 1992 83 4 329 333
137. Bellas C., Mampaso F., Fraile G., Molina A., Bricio T., Cuesta C., Detection of Epstein-Barr genome in the lymph nodes of Hodgkin's disease Postgraduate Medical Journal 1993 69 818 916 919 (Pubitemid 24028088)
138. Carbone A., Gloghini A., Zanette I., Canal B., Rizzo A., Volpe R., Co-expression of Epstein-Barr virus latent membrane protein and vimentin in 'aggressive' histological subtypes of Hodgkin's disease Virchows Archiv 1993 422 1 39 45 (Pubitemid 23073663)
139. Coates P. J., D'Ardenne A. J., Slavin G., Kingston J. E., Malpas J. S., Detection of Epstein-Barr virus in Reed-Sternberg cells of Hodgkin's disease arising in children Medical and Pediatric Oncology 1993 21 1 19 23 (Pubitemid 23018171)
140. Kapatai G., Murray P., Contribution of the Epstein-Barr virus to the molecular pathogenesis of Hodgkin lymphoma Journal of Clinical Pathology 2007 60 12 1342 1349 (Pubitemid 350252944)
141. Cohen J. I., Epstein-Barr virus infection New England Journal of Medicine 2000 343 7 481 492 (Pubitemid 30646489)
142. Glaser S. L., Lin R. J., Stewart S. L., Ambinder R. F., Jarrett R. F., Brousset P., Pallesen G., Gulley M. L., Khan G., O'Grady J., Hummel M., Preciado M. V., Knecht H., Chan J. K. C., Claviez A., Epstein-Barr virus-associated Hodgkin's disease: epidemiologic characteristics in international data International Journal of Cancer 1997 70 4 375 382 (Pubitemid 27107262)
143. Murray P. G., Billingham L. J., Hassan H. T., Flavell J. R., Nelson P. N., Scott K., Reynolds G., Constandinou C. M., Kerr D. J., Devey E. C., Crocker J., Young L. S., Effect of Epstein-Barr virus infection on response to chemotherapy and survival in Hodgkin's disease Blood 1999 94 2 442 447 (Pubitemid 29323858)
144. Flavell K. J., Billingham L. J., Biddulph J. P., Gray L., Flavell J. R., Constandinou C. M., Young L. S., Murray P. G., The effect of Epstein-Barr virus status on outcome in age- and sex-defined subgroups of patients with advanced Hodgkin's disease Annals of Oncology 2003 14 2 282 290 (Pubitemid 36305442)
145. Jarrett R. F., Stark G. L., White J., Angus B., Alexander F. E., Krajewski A. S., Freeland J., Taylor G. M., Taylor P. R. A., Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study Blood 2005 106 7 2444 2451 (Pubitemid 41510819)
146. Kamper P. M., Kjeldsen E., Clausen N., Bendix K., Hamilton-Dutoit S., D'Amore F., Epstein-Barr virus-associated familial Hodgkin lymphoma: paediatric onset in three of five siblings British Journal of Haematology 2005 129 5 615 617 (Pubitemid 40825822)
147. Diepstra A., Niens M., Vellenga E., Van Imhoff G. W., Nolte I. M., Schaapveld M., Van Der Steege G., Van Den Berg A., Kibbelaar R. E., Te Meerman G. J., Poppema S., Association with HLA class I in Epstein-Barr-virus-positive and with HLA class III in Epstein-Barr-virus-negative Hodgkin's lymphoma Lancet 2005 365 9478 2216 2224 (Pubitemid 40853915)
148. Diepstra A., van Imhoff G. W., Karim-Kos H. E., Van Den Berg A., Te Meerman G. J., Niens M., Nolte I. M., Bastiaannet E., Schaapveld M., Vellenga E., Poppema S., HLA class II expression by Hodgkin Reed-Sternberg cells is an independent prognostic factor in classical Hodgkin's lymphoma Journal of Clinical Oncology 2007 25 21 3101 3108 (Pubitemid 47218058)
149. Niens M., Jarrett R. F., Hepkema B., Nolte I. M., Diepstra A., Platteel M., Kouprie N., Delury C. P., Gallagher A., Visser L., Poppema S., Te Meerman G. J., Van Den Berg A., HLA-A02 is associated with a reduced risk and HLA-A01 with an increased risk of developing EBV+Hodgkin lymphoma Blood 2007 110 9 3310 3315 (Pubitemid 350106324)
150. Fingeroth J. D., Weis J. J., Tedder T. F., Strominger J. L., Biro P. A., Fearon D. T., Epstein-Barr virus receptor of human B lymphocytes is the C3d receptor CR2 Proceedings of the National Academy of Sciences of the United States of America 1984 81 14 4510 4514 (Pubitemid 14055921)
151. Li Q., Spriggs M. K., Kovats S., Turk S. M., Comeau M. R., Nepom B., Hutt-Fletcher L. M., Epstein-Barr virus uses HLA class II as a cofactor for infection of B lymphocytes Journal of Virology 1997 71 6 4657 4662 (Pubitemid 27204158)
152. Nemerow G. R., Mold C., Schwend V. K., Tollefson V., Cooper N. R., Identification of gp350 as the viral glycoprotein mediating attachment of Epstein-Barr virus (EBV) to the EBV/C3d receptor of B cells: sequence homology of gp350 and C3 complement fragment C3d Journal of Virology 1987 61 5 1416 1420 (Pubitemid 17069728)
153. Babcock G. J., Decker L. L., Freeman R. B., Thorley-Lawson D. A., Epstein-Barr virus-infected resting memory B cells, not proliferating lymphoblasts, accumulate in the peripheral blood of immunosuppressed patients Journal of Experimental Medicine 1999 190 4 567 576 (Pubitemid 29395384)
154. Babcock G. J., Decker L. L., Volk M., Thorley-Lawson D. A., EBV persistence in memory B cells in vivo Immunity 1998 9 3 395 404 (Pubitemid 28462760)
155. Kieff E., Fields B. N., Knipe D. M., Howley P. M., Epstein-Barr virus and its replication Virology 1996 Philadelphia, Pa, USA Lippincott-Raven 2343 2396
156. Chapman A. L. N., Rickinson A. B., Epstein-Barr virus in Hodgkin's disease Annals of Oncology 1998 9 5 S5 S16
157. Miyazaki I., Cheung R. K., Dosch H. M., Viral interleukin 10 is critical for the induction of B cell growth transformation by Epstein-Barr virus Journal of Experimental Medicine 1993 178 2 439 447 (Pubitemid 23218192)
158. Cohen S. B. A., Crawley J. B., Kahan M. C., Feldmann M., Foxwell B. M. J., Interleukin-10 rescues T cells from apoptotic cell death: association with an upregulation of Bcl-2 Immunology 1997 92 1 1 5 (Pubitemid 27380873)
159. Fiorentino D. F., Zlotnik A., Mosmann T. R., Howard M., O'Garra A., IL-10 inhibits cytokine production by activated macrophages Journal of Immunology 1991 147 11 3815 3822
160. Fiorentino D. F., Zlotnik A., Vieira P., Mosmann T. R., Howard M., Moore K. W., O'Garra A., IL-10 acts on the antigen-presenting cell to inhibit cytokine production by Th1 cells Journal of Immunology 1991 146 10 3444 3451
161. Hohaus S., Giachelia M., Di Febo A., Martini M., Massini G., Vannata B., D'Alo' F., Guidi F., Greco M., Pierconti F., Larocca L. M., Voso M. T., Leone G., Polymorphism in cytokine genes as prognostic markers in Hodgkin's lymphoma Annals of Oncology 2007 18 8 1376 1381 (Pubitemid 47305013)
162. Kilger E., Kieser A., Baumann M., Hammerschmidt W., Epstein-Barr virus-mediated B-cell proliferation is dependent upon latent membrane protein 1, which simulates an activated CD40 receptor EMBO Journal 1998 17 6 1700 1709 (Pubitemid 28119123)
163. Mancao C., Hammerschmidt W., Epstein-Barr virus latent membrane protein 2A is a B-cell receptor mimic and essential for B-cell survival Blood 2007 110 10 3715 3721 (Pubitemid 350159641)
164. Klein G., Klein E., Kashuba E., Interaction of Epstein-Barr virus (EBV) with human B-lymphocytes Biochemical and Biophysical Research Communications 2010 396 1 67 73
165. Calderwood M. A., Venkatesan K., Xing L., Chase M. R., Vazquez A., Holthaus A. M., Ewence A. E., Li N., Hirozane-Kishikawa T., Hill D. E., Vidal M., Kieff E., Johannsen E., Epstein-Barr virus and virus human protein interaction maps Proceedings of the National Academy of Sciences of the United States of America 2007 104 18 7606 7611 (Pubitemid 47185953)
166. Fadlelmola F. M., Zhou M., de Leeuw R. J., Dosanjh N. S., Harmer K., Huntsman D., Lam W. L., Banerjee D., Sub-megabase resolution tiling (SMRT) array-based comparative genomic hybridization profiling reveals novel gains and losses of chromosomal regions in Hodgkin Lymphoma and Anaplastic Large Cell Lymphoma cell lines Molecular Cancer 2008 7, article 2
167. Hartmann S., Martin-Subero J. I., Gesk S., Hsken J., Giefing M., Nagel I., Riemke J., Chott A., Klapper W., Parrens M., Merlio J. P., Kppers R., Bruninger A., Siebert R., Hansmann M. L., Detection of genomic imbalances in microdissected Hodgkin and Reed-Sternberg cells of classical Hodgkin's lymphoma by array-based comparative genomic hybridization Haematologica 2008 93 9 1318 1326
168. Steidl C., Telenius A., Shah S. P., Farinha P., Barclay L., Boyle M., Connors J. M., Horsman D. E., Gascoyne R. D., Genome-wide copy number analysis of Hodgkin Reed-Sternberg cells identifies recurrent imbalances with correlations to treatment outcome Blood 2010 116 3 418 427
169. Leslie E. M., Deeley R. G., Cole S. P. C., Toxicological relevance of the multidrug resistance protein 1, MRP1 (ABCC1) and related transporters Toxicology 2001 167 1 3 23 (Pubitemid 32830943)
170. Rosenberg M. F., Mao Q., Holzenburg A., Ford R. C., Deeley R. G., Cole S. P. C., The structure of the multidrug resistance protein 1 (MRP1/ABCC1): crystallization and single-particle analysis Journal of Biological Chemistry 2001 276 19 16076 16082
171. Devilard E., Bertucci F., Trempat P., Bouabdallah R., Loriod B., Giaconia A., Brousset P., Granjeaud S., Nguyen C., Birnbaum D., Birg F., Houlgatte R., Xerri L., Gene expression profiling defines molecular subtypes of classical Hodgkin's disease Oncogene 2002 21 19 3095 3102 (Pubitemid 34522911)
172. Kirchner J., Bevan M. J., ITM2A is induced during thymocyte selection and T cell activation and causes downregulation of CD8 when overexpressed in CD4+CD8+ double positive thymocytes Journal of Experimental Medicine 1999 190 2 217 228 (Pubitemid 29354915)
173. Terai Y., Abe M., Miyamoto K., Koike M., Yamasaki M., Ueda M., Ueki M., Sato Y., Vascular smooth muscle cell growth-promoting factor/F-spondin inhibits angiogenesis via the blockade of integrin v 3 on vascular endothelial cells Journal of Cellular Physiology 2001 188 3 394 402 (Pubitemid 32777181)
174. Miyamoto K., Morishita Y., Yamazaki M., Minamino N., Kangawa K., Matsuo H., Mizutani T., Yamada K., Minegishi T., Isolation and characterization of vascular smooth muscle cell growth promoting factor from bovine ovarian follicular fluid and its cDNA cloning from bovine and human ovary Archives of Biochemistry and Biophysics 2001 390 1 93 100 (Pubitemid 32493574)
175. Ruf W., Yokota N., Schaffner F., Tissue factor in cancer progression and angiogenesis Thrombosis research 2010 125 supplement 2 S36 38
176. Shinkai A., Komuta-Kunitomo M., Sato-Nakamura N., Anazawa H., N-terminal domain of eotaxin-3 is important for activation of CC chemokine receptor 3 Protein Engineering 2002 15 11 923 929 (Pubitemid 36172730)
177. Shinkai A., Yoshisue H., Koike M., Shoji E., Nakagawa S., Saito A., Takeda T., Imabeppu S., Kato Y., Hanai N., Anazawa H., Kuga T., Nishi T., A novel human CC chemokine eotaxin-3, which is expressed in IL-4- stimulated vascular endothelial cells, exhibits potent activity toward eosinophils Journal of Immunology 1999 163 3 1602 1610 (Pubitemid 29352785)
178. Nakamura S., Nagahama M., Kagami Y., Yatabe Y., Takeuchi T., Kojima M., Motoori T., Suzuki R., Taji H., Ogura M., Mizoguchi Y., Okamoto M., Suzuki H., Oyama A., Seto M., Morishima Y., Koshikawa T., Takahashi T., Kurita S., Suchi T., Hodgkin's disease expressing follicular dendritic cell marker CD21 without any other B-cell marker: a clinicopathologic study of nine cases American Journal of Surgical Pathology 1999 23 4 363 376 (Pubitemid 29159997)
179. Mohan J., Dement-Brown J., Maier S., Ise T., Kempkes B., Tolnay M., Epstein-Barr virus nuclear antigen 2 induces FcRH5 expression through CBF1 Blood 2006 107 11 4433 4439 (Pubitemid 43801370)
180. Adorini L., Penna G., Induction of tolerogenic dendritic cells by vitamin D receptor agonists Handbook of Experimental Pharmacology 2009 188 251 273
181. Kang Y., Taldone T., Clement C. C., Fewell S. W., Aguirre J., Brodsky J. L., Chiosis G., Design of a fluorescence polarization assay platform for the study of human Hsp70 Bioorganic and Medicinal Chemistry Letters 2008 18 13 3749 3751 (Pubitemid 351794512)
182. Ma X., Zhao H., Shan J., Long F., Chen Y., Chen Y., Zhang Y., Han X., Ma D., PDCD10 interacts with Ste20-related kinase MST4 to promote cell growth and transformation via modulation of the ERK pathway Molecular Biology of the Cell 2007 18 6 1965 1978 (Pubitemid 46911350)
183. Marchetti F., Venkatachalam S., The multiple roles of Bub1 in chromosome segregation during mitosis and meiosis Cell Cycle 2010 9 1 58 63
184. Tang L. Y., Deng N., Wang L. S., Dai J., Wang Z. L., Jiang X. S., Li SU. J., Li L., Sheng Q. H., Wu D. Q., Li L., Zeng R., Quantitative phosphoproteome profiling of Wnt3a-mediated signaling network: Indicating the involvement of ribonucleoside-diphosphate reductase M2 subunit phosphorylation at residue serine 20 in canonical Wnt signal transduction Molecular and Cellular Proteomics 2007 6 11 1952 1967 (Pubitemid 350201870)
185. Chetaille B., Bertucci F., Finetti P., Esterni B., Stamatoullas A., Picquenot J. M., Copin M. C., Morschhauser F., Casasnovas O., Petrella T., Molina T., Vekhoff A., Feugier P., Bouabdallah R., Birnbaum D., Olive D., Xerri L., Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcome Blood 2009 113 12 2765 2775
186. Brune V., Tiacci E., Pfeil I., Dring C., Eckerle S., Van Noesel C. J. M., Klapper W., Falini B., Von Heydebreck A., Metzler D., Bruninger A., Hansmann M. L., Kppers R., Origin and pathogenesis of nodular lymphocyte-predominant Hodgkin lymphoma as revealed by global gene expression analysis Journal of Experimental Medicine 2008 205 10 2251 2268
187. Desfranois J., Moreau-Aubry A., Vignard V., Godet Y., Khammari A., Drno B., Jotereau F., Gervois N., Double positive CD4CD8 T cells: a new tumor-reactive population in human melanomas PLoS ONE 2010 5 1, article e8437
188. Desfranois J., Derr L., Corvaisier M., Le Mvel B., Catros V., Jotereau F., Gervois N., Increased frequency of nonconventional double positive CD4CD8 T cells in human breast pleural effusions International Journal of Cancer 2009 125 2 374 380
189. Zuckermann F. A., Extrathymic CD4/CD8 double positive T cells Veterinary Immunology and Immunopathology 1999 72 1-2 55 66
190. Ghia P., Prato G., Stella S., Scielzo C., Geuna M., Caligaris-Cappio F., Age-dependent accumulation of monoclonal CD4CD8 double positive T lymphocytes in the peripheral blood of the elderly British Journal of Haematology 2007 139 5 780 790 (Pubitemid 350115731)
191. Carella A. M., Carlier P., Congiu A., Occhini D., Meloni G., Anselmo Mandelli A. P. F., Mazza P., Tura S., Mangoni L., Rizzoli V., Fabris P., Coser P., Levis A., Locatelli L., Resegotti L., Porcellini A., Benedetti F., Allesandrino E. P., Nine years' experience with ABMT in 128 patients with Hodgkin's disease: an Italian study group report Leukemia 1991 5 supplement 1 68 71
192. Mendler J. H., Friedberg J. W., Salvage therapy in Hodgkin's lymphoma Oncologist 2009 14 4 425 432
193. Seftel M., Rubinger M., The role of hematopoietic stem cell transplantation in advanced Hodgkin Lymphoma Transfusion and Apheresis Science 2007 37 1 49 56 (Pubitemid 47576785)
194. Fung H. C., Stiff P., Schriber J., Toor A., Smith E., Rodriguez T., Krishnan A., Molina A., Smith D., Ivers B., Kogut N., Popplewell L., Rodriguez R., Somlo G., Forman S. J., Nademanee A., Tandem autologous stem cell transplantation for patients with primary refractory or poor risk recurrent Hodgkin lymphoma Biology of Blood and Marrow Transplantation 2007 13 5 594 600 (Pubitemid 46585934)
195. Kewalramani T., Nimer S. D., Zelenetz A. D., Malhotra S., Qin J., Yahalom J., Moskowitz C. H., Progressive disease following autologous transplantation in patients with chemosensitive relapsed or primary refractory Hodgkin's disease or aggressive non-Hodgkin's lymphoma Bone Marrow Transplantation 2003 32 7 673 679 (Pubitemid 37258622)
196. Steidl C., Lee T., Shah S. P., Farinha P., Han G., Nayar T., Delaney A., Jones S. J., Iqbal J., Weisenburger D. D., Bast M. A., Rosenwald A., Muller-Hermelink H. K., Rimsza L. M., Campo E., Delabie J., Braziel R. M., Cook J. R., Tubbs R. R., Jaffe E. S., Lenz G., Connors J. M., Staudt L. M., Chan W. C., Gascoyne R. D., Tumor-associated macrophages and survival in classic Hodgkin's lymphoma New England Journal of Medicine 2010 362 10 875 885
197. DeVita V. T., Costa J., Toward a personalized treatment of Hodgkin's disease New England Journal of Medicine 2010 362 10 942 943
198. Laitala-Leinonen T., Update on the development of microRNA and siRNA molecules as regulators of cell physiology Recent Patents on DNA Gene Sequences 2010 4 2 113 121
199. Kluiver J., Poppema S., de Jong D., Blokzijl T., Harms G., Jacobs S., Kroesen B. J., van den Berg A., BIC and miR-155 are highly expressed in Hodgkin, primary mediastinal and diffuse large B cell lymphomas Journal of Pathology 2005 207 2 243 249 (Pubitemid 41404155)
200. Gatto G., Rossi A., Rossi D., Kroening S., Bonatti S., Mallardo M., Epstein-Barr virus latent membrane protein 1 trans-activates miR-155 transcription through the NF- B pathway Nucleic Acids Research 2008 36 20 6608 6619
201. Gibcus J. H., Tan L. P., Harms G., Schakel R. N., De Jong D., Blokzijl T., Mller P., Poppema S., Kroesen B. J., Van Den Berg A., Hodgkin lymphoma cell lines are characterized by a specific miRNA expression profile Neoplasia 2009 11 2 167 176
202. Navarro A., Gaya A., Martinez A., Urbano-Ispizua A., Pons A., Balagu O., Gel B., Abrisqueta P., Lopez-Guillermo A., Artells R., Montserrat E., Monzo M., MicroRNA expression profiling in classic Hodgkin lymphoma Blood 2008 111 5 2825 2832
203. Nie K., Gomez M., Landgraf P., Garcia J. F., Liu Y., Tan L. H. C., Chadburn A., Tuschl T., Knowles D. M., Tam W., MicroRNA-mediated down-regulation of PRDM1/Blimp-1 in Hodgkin/Reed- Sternberg cells: a potential pathogenetic lesion in Hodgkin lymphomas American Journal of Pathology 2008 173 1 242 252 (Pubitemid 351947971)
204. Navarro A., Diaz T., Martinez A., Gaya A., Pons A., Gel B., Codony C., Ferrer G., Martinez C., Montserrat E., Monzo M., Regulation of JAK2 by miR-135a: prognostic impact in classic Hodgkin lymphoma Blood 2009 114 14 2945 2951
205. van Vlierberghe P., de Weer A., Mestdagh P., Feys T., De Preter K., De Paepe P., Lambein K., Vandesompele JO., Van Roy N., Verhasselt B., Poppe B., Speleman F., Comparison of miRNA profiles of microdissected Hodgkin/Reed- Sternberg cells and Hodgkin cell lines versus CD77 B-cells reveals a distinct subset of differentially expressed miRNAs British Journal of Haematology 2009 147 5 686 690
206. Yoshimura A., Regulation of cytokine signaling by the SOCS and Spred family proteins Keio Journal of Medicine 2009 58 2 73 83
207. Buckler J. L., Liu X., Turka L. A., Regulation of T-cell responses by PTEN Immunological Reviews 2008 224 1 239 248
208. Nieters A., Beckmann L., Deeg E., Becker N., Gene polymorphisms in Toll-like receptors, interleukin-10, and interleukin-10 receptor alpha and lymphoma risk Genes and Immunity 2006 7 8 615 624 (Pubitemid 46242365)
209. Hohaus S., Giachelia M., Massini G., Vannata B., Criscuolo M., Martini M., D'Alo' F., Voso M. T., Larocca L. M., Leone G., Clinical significance of interleukin-10 gene polymorphisms and plasma levels in Hodgkin lymphoma Leukemia Research 2009 33 10 1352 1356
210. Chang E. T., Zheng T., Weir E. G., Borowitz M., Mann R. B., Spiegelman D., Meuller N. E., Aspirin and the risk of Hodgkin's lymphoma in a population-based case-control study Journal of the National Cancer Institute 2004 96 4 305 315 (Pubitemid 38256275)
211. Yamamoto Y., Yin M. J., Lin K. M., Gaynor R. B., Sulindac inhibits activation of the NF- B pathway Journal of Biological Chemistry 1999 274 38 27307 27314
212. Chang E. T., Birmann B. M., Kasperzyk J. L., Conti D. V., Kraft P., Ambinder R. F., Zheng T., Mueller N. E., Polymorphic variation in NFKB1 and other aspirin-related genes and risk of Hodgkin lymphoma Cancer Epidemiology Biomarkers and Prevention 2009 18 3 976 986
213. Chang E. T., Cronin-Fenton D. P., Friis S., Hjalgrim H., Srensen H. T., Pedersen L., Aspirin and other nonsteroidal anti-inflammatory drugs in relation to Hodgkin lymphoma risk in Northern Denmark Cancer Epidemiology Biomarkers and Prevention 2010 19 1 59 64
214. El-Zein R., Monroy C. M., Etzel C. J., Cortes A. C., Xing Y., Collier A. L., Strom S. S., Genetic polymorphisms in DNA repair genes as modulators of Hodgkin disease risk Cancer 2009 115 8 1651 1659
215. Shafer J. A., Cruz C. R., Leen A. M., Ku S., Lu AN., Rousseau A., Heslop H. E., Rooney C. M., Bollard C. M., Foster A. E., Antigen-specific cytotoxic T lymphocytes can target chemoresistant side-population tumor cells in Hodgkin lymphoma Leukemia and Lymphoma 2010 51 5 870 880
216. Staege M. S., Banning-Eichenseer U., Weiflog G., Volkmer I., Burdach S., Richter G., Mauz-Krholz C., Fll J., Krholz D., Gene expression profiles of Hodgkin's lymphoma cell lines with different sensitivity to cytotoxic drugs Experimental Hematology 2008 36 7 886 896
217. Kashkar H., Deggerich A., Seeger J. M., Yazdanpanah B., Wiegmann K., Haubert D., Pongratz C., Krnke M., NF- B-independent down-regulation of XIAP by bortezomib sensitizes HL B cells against cytotoxic drugs Blood 2007 109 9 3982 3988 (Pubitemid 46641751)
218. Foyil K. V., Bartlett N. L., Anti-CD30 antibodies for Hodgkin lymphoma Current Hematologic Malignancy Reports 2010 5 3 140 147
219. uli S., Armanda V., Kuljis D., Kuzmic I., Pranic-Kragic A., Jankovic S., Anti-CD20 monoclonal antibody (rituximab) for therapy of cd20-positive nodular lymphocyte-predominant Hodgkin lymphoma in an 10-year-old girl Pediatric Hematology and Oncology 2006 23 8 661 666 (Pubitemid 44653063)
220. Zojer N., Mirzaei S., Ludwig H., Successful treatment of a patient with lymphocyte-predominant Hodgkin's lymphoma with yttrium-90-ibritumomab tiuxetan European Journal of Haematology 2008 81 4 322 324
221. Schulz H., Rehwald U., Morschhauser F., Elter T., Driessen C., Rdiger T., Borchmann P., Schnell R., Diehl V., Engert A., Reiser M., Rituximab in relapsed lymphocyte-predominant Hodgkin lymphoma: long-term results of a phase 2 trial by the German Hodgkin Lymphoma Study Group (GHSG) Blood 2008 111 1 109 111
222. Ekstrand B. C., Lucas J. B., Horwitz S. M., Fan Z., Breslin S., Hoppe R. T., Natkunam Y., Bartlett N. L., Horning S. J., Rituximab in lymphocyte-predominant Hodgkin disease: results of a phase 2 trial Blood 2003 101 11 4285 4289 (Pubitemid 36857790)
223. Pijuan L., Vicioso L., Bellosillo B., Ferrer M. D., Bar T., Pedro C., Lloreta-Trull J., Munn A., Serrano S., CD20-negative t-cell-rich b-cell lymphoma as a progression of a nodular lymphocyte-predominant Hodgkin's lymphoma treated with rituximabL: a molecular analysis using laser capture microdissection American Journal of Surgical Pathology 2005 29 10 1399 1403 (Pubitemid 41368778)
224. Jundt F., Acikgz O., Kwon S. H., Schwarzer R., Anagnostopoulos I., Wiesner B., Mathas S., Hummel M., Stein H., Reichardt H. M., Drken B., Aberrant expression of Notch1 interferes with the B-lymphoid phenotype of neoplastic B cells in classical Hodgkin lymphoma Leukemia 2008 22 8 1587 1594
225. Vockerodt M., Morgan S. L., Kuo M., Wei W., Chukwuma M. B., Arrand J. R., Kube D., Gordon J., Young L. S., Woodman C. B., Murray P. G., The Epstein-Barr virus oncoprotein, latent membrane protein-1, reprograms germinal centre B cells towards a Hodgkin's Reed-Sternberg-like phenotype Journal of Pathology 2008 216 1 83 92
226. Schwering I., Bruninger A., Klein U., Jungnickel B., Tinguely M., Diehl V., Hansmann M. L., Dalla-Favera R., Rajewsky K., Kppers R., Loss of the B-lineage-specific gene expression program in Hodgkin and Reed-Sternberg cells of Hodgkin lymphoma Blood 2003 101 4 1505 1512 (Pubitemid 36182527)
227. Oki Y., Younes A., Does rituximab have a place in treating classic Hodgkin lymphoma? Current Hematologic Malignancy Reports 2010 5 3 135 139
228. Jones R. J., Gocke C. D., Kasamon Y. L., Miller C. B., Perkins B., Barber J. P., Vala M. S., Gerber J. M., Gellert L. L., Siedner M., Lemas M. V., Brennan S., Ambinder R. F., Matsui W., Circulating clonotypic B cells in classic Hodgkin lymphoma Blood 2009 113 23 5920 5926
229. Younes A., Romaguera J., Hagemeister F., McLaughlin P., Rodriguez M. A., Fiumara P., Goy A., Jeha S., Manning J. T., Jones D., Abruzzo L. V., Medeiros L. J., A pilot study of rituximab in patients with recurrent, classic Hodgkin disease Cancer 2003 98 2 310 314 (Pubitemid 36828455)
230. Oki Y., Pro B., Fayad L. E., Romaguera J., Samaniego F., Hagemeister F., Neelapu S., McLaughlin P., Goy A., Younes A., Phase 2 study of gemcitabine in combination with rituximab in patients with recurrent or refractory Hodgkin lymphoma Cancer 2008 112 4 831 836 (Pubitemid 351240577)
231. Corazzelli G., Capobianco G., Arcamone M., Rituximab plus gemcitabine, ifosfamide, oxaliplatin (R-GIFOX) as salvage therapy for recurrent Hodgkin lymphoma Journal of Clinical Oncology 2009 27, article 15s
232. Copeland A. R., Cao Y., Fanale M., Final report of a phase-II study of rituximab plus ABVD for patients with newly diagnosed advanced stage classical Hodgkin lymphoma.: results of long follow up and comparison to institutional historical data Blood 2009 114, article 1680
233. Wedgwood A., Fanale M., Fayad L., Rituximab + ABVD improves event-free survival (EFS) in patients with classical Hodgkin lymphoma in all International Prognostic Score (IPS) groups and in patients who have PET positive disease after 2-3 cycles of therapy Blood 2008 110, article 215
234. Wahl A. F., Klussman K., Thompson J. D., Chen J. H., Francisco L. V., Risdon G., Chace D. F., Siegall C. B., Francisco J. A., The anti-CD30 monoclonal antibody SGN-30 promotes growth arrest and DNA fragmentation in Vitro and affects antitumor activity in models of Hodgkin's disease Cancer Research 2002 62 13 3736 3742 (Pubitemid 34728855)
235. Cerveny C. G., Law C. L., McCormick R. S., Lenox J. S., Hamblett K. J., Westendorf L. E., Yamane A. K., Petroziello J. M., Francisco J. A., Wahl A. F., Signaling via the anti-CD30 mAb SGN-30 sensitizes Hodgkin's disease cells to conventional chemotherapeutics Leukemia 2005 19 9 1648 1655 (Pubitemid 43090411)
236. Oflazoglu E., Stone I. J., Gordon K. A., Grewal I. S., Van Rooijen N., Law C. L., Gerber H. P., Macrophages contribute to the antitumor activity of the anti-CD30 antibody SGN-30 Blood 2007 110 13 4370 4372 (Pubitemid 351377803)
237. Forero-Torres A., Leonard J. P., Younes A., Rosenblatt J. D., Brice P., Bartlett N. L., Bosly A., Pinter-Brown L., Kennedy D., Sievers E. L., Gopal A. K., A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma British Journal of Haematology 2009 146 2 171 179
238. Hu X. F., Xing P. X., MDX-060 medarex Current Opinion in Investigational Drugs 2005 6 12 1266 1271 (Pubitemid 43009208)
239. Ansell S. M., Horwitz S. M., Engert A., Khan K. D., Lin T., Strair R., Keler T., Graziano R., Blanset D., Yellin M., Fischkoff S., Assad A., Borchmann P., Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma Journal of Clinical Oncology 2007 25 19 2764 2769 (Pubitemid 47123185)
240. Francisco J. A., Cerveny C. G., Meyer D. L., Mixan B. J., Klussman K., Chace D. F., Rejniak S. X., Gordon K. A., DeBlanc R., Toki B. E., Law C. L., Doronina S. O., Siegall C. B., Senter P. D., Wahl A. F., cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity Blood 2003 102 4 1458 1465 (Pubitemid 36988057)
241. Younes A., Forero-Torres A., Bartlett N. L., Objective responses in a phase I dose-escalation study of SGN-35, a novel antibody-drug conjugate (ADC) targeting CD30, in patients with relapsed or refractory Hodgkin lymphoma Proceedings of Annual Meeting American Society of Clinical Oncology (ASCO '08) 2008
242. Younes A., Forero-Torres A., Bartlett N. L., Multiple complete responses in a phase 1 dose-escalation study of the antibody-drug conjugate SGN-35 in patients with relapsed or refractory CD30-positive lymphomas Proceedings of the 50th ASH Annual Meeting 2008 San Frncisco, Calif, USA
243. Okeley N. M., Miyamoto J. B., Zhang X., Sanderson R. J., Benjamin D. R., Sievers E. L., Senter P. D., Alley S. C., Intracellular activation of SGN-35, a potent anti-CD30 antibody-drug conjugate Clinical Cancer Research 2010 16 3 888 897
244. Dennie T. W., Kolesar J. M., Bendamustine for the treatment of chronic lymphocytic leukemia and rituximab-refractory, indolent B-cell non-Hodgkin lymphoma Clinical Therapeutics 2009 31 2 2290 2311
245. Cheson B. D., Rummel M. J., Bendamustine: rebirth of an old drug Journal of Clinical Oncology 2009 27 9 1492 1501
246. Friedberg J. W., Cohen P., Chen L., Robinson K. S., Forero-Torres A., La Casce A. S., Fayad L. E., Bessudo A., Camacho E. S., Williams M. E., Van Der Jagt R. H., Oliver J. W., Cheson B. D., Bendamustine in patients with rituximab-refractory indolent and transformed non-Hodgkin's lymphoma: results from a phase II multicenter, single-agent study Journal of Clinical Oncology 2008 26 2 204 210
247. Moskowitz A. J., Hamlin P. A. Jr., Gerecitano J., Bendamustine is highly active in heavily pre-treated relapsed and refractory Hodgkin Lymphoma and serves as a bridge to allogeneic stem cell transplant 114 Proceedings of ASH Annual Meeting Abstracts 2009 720
248. Fehniger T. A., Larson S., Trinkaus K., A phase II multicenter study of lenalidomide in relapsed or refractory classical Hodgkin lymphoma 114 Proceedings of ASH Annual Meeting Abstracts 2009 3693
249. Bll B., Borchmann P., Topp M. S., Hnel M., Reiners K. S., Engert A., Naumann R., Lenalidomide in patients with refractory or multiple relapsed Hodgkin lymphoma British Journal of Haematology 2010 148 3 480 482
250. Weniger M. A., Barth T. F. E., Mller P., Genomic alterations in Hodgkin's lymphoma International Journal of Hematology 2006 83 5 379 384 (Pubitemid 44756786)
251. Buglio D., Mamidipudi V., Khaskhely N. M., Brady H., Heise C., Besterman J., Martell R. E., MacBeth K., Younes A., The class-I HDAC inhibitor MGCD0103 induces apoptosis in Hodgkin lymphoma cell lines and synergizes with proteasome inhibitors by an HDAC6-independent mechanism British Journal of Haematology 2010 151 4 387 396
252. Hartlapp I., Pallasch C., Weibert G., Kemkers A., Hummel M., Re D., Depsipeptide induces cell death in Hodgkin lymphoma-derived cell lines Leukemia Research 2009 33 7 929 936
253. Gloghini A., Buglio D., Khaskhely N. M., Georgakis G., Orlowski R. Z., Neelapu S. S., Carbone A., Younes A., Expression of histone deacetylases in lymphoma: implication for the development of selective inhibitors British Journal of Haematology 2009 147 4 515 525
254. Buglio D., Georgakis G. V., Hanabuchi S., Arima K., Khaskhely N. M., Liu Y. J., Younes A., Vorinostat inhibits STAT6-mediated TH2 cytokine and TARC production and induces cell death in Hodgkin lymphoma cell lines Blood 2008 112 4 1424 1433
255. Adams H., Fritzsche F. R., Dirnhofer S., Kristiansen G., Tzankov A., Class i histone deacetylases 1, 2 and 3 are highly expressed in classical Hodgkin's lymphoma Expert Opinion on Therapeutic Targets 2010 14 6 577 584
256. Younes A., Pro B., Fanale M., Isotype-selective HDAC inhibitor MGCD0103 decreases serum TARC concentrations and produces clinical responses in heavily pretreated patients with relapsed classical Hodgkin lymphoma (HL) 110 Proceedings of the ASH Annual Meeting Abstracts 2007 2566
257. Zhou M., Fadlelmola F. M., Cohn J. B., Skinnider B., Gascoyne R. D., Banerjee D., Constitutive overexpression of a novel 21 kDa protein by Hodgkin lymphoma and aggressive non-Hodgkin lymphomas Molecular Cancer 2008 7, article 12
258. Murphy D., Parker J., Zhou M., Fadlelmola F. M., Steidl C., Karsan A., Gascoyne R. D., Chen H., Banerjee D., Constitutively overexpressed 21 kDa protein in Hodgkin lymphoma and aggressive non-Hodgkin lymphomas identified as cytochrome B(CYB5B) Molecular Cancer 2010 9, article 1